At a glance
ClinicalIndex Comparison RecordN/ACompleted· 70 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Inflammatory Hematological Markers in Idiopathic Carpal Tunnel Syndrome
In Brief
An observational study for Carpal Tunnel Syndrome (CTS) and Biomarkers / Blood. Completed, enrolled 70 participants across 1 site.
Detailed Summary
Carpal Tunnel Syndrome (CTS) cases are still classified as idiopathic. The rationale of this research is to investigate the role of chronic inflammation and vitamin B12 deficiency in the onset and severity of idiopathic CTS. This case-control study aims to evaluate inflammatory hematological markers and vitamin B12 levels in patients with idiopathic CTS compared to healthy controls, and to analyze their correlation with clinical and electrophysiological severity of the disease
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCarpal Tunnel Syndrome (CTS), Biomarkers / Blood
CountriesTurkey (Türkiye)
Collaborators--
Timeline
N/ACompletedFinished
2026
Enrollment StartApr 2025
First PostedMay 2025
Primary CompletionJan 2026
Study CompletionJan 2026
TodayJul 2026
First PostedMay 1, 2025
Enrollment StartApr 1, 2025
Primary CompletionJan 15, 2026
Study CompletionJan 20, 2026
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 1.2 years ago